Anaphylactic reactions presenting with hypertension
Background Although a few case reports about hypertensive anaphylaxis (HA) are available in the present literature, there is no study about the prevalence of HA. In this study, we review our cases with anaphylaxis presenting with hypertension and ascertain its prevalence. The documents of the patients who had anaphylactic reactions after the procedures performed for the diagnosis and treatment of allergic diseases in GATA Haydarpasa Clinic of Allergy and Immunology between January 2010 and December 2014 were retrospectively reviewed. Within the study period, 324 patients had undergone 4332 procedures in which 62 of them had developed anaphylaxis. Results During the procedures, the rate of anaphylaxis was found to be 1.43 %. The rate of HA among the anaphylaxis patients was 12.9 % (8 of 62 patients). During treatments, 2 patients received adrenaline injections without any adverse reaction. Conclusions HA may be seen at a considerable rate during an anaphylactic reaction. Anaphylaxis and hypertension can be recovered by adrenaline injection when required. According to the best of our knowledge, this study is the first original study about the prevalence of HA in English-language medical literature..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
|---|---|
| Enthalten in: |
SpringerPlus - 5(2016), 1 vom: 02. Aug. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Solmazgul, Emrullah [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1186/s40064-016-2913-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR032788622 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR032788622 | ||
| 003 | DE-627 | ||
| 005 | 20230519164216.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s40064-016-2913-y |2 doi | |
| 035 | |a (DE-627)SPR032788622 | ||
| 035 | |a (SPR)s40064-016-2913-y-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 600 |q ASE |
| 100 | 1 | |a Solmazgul, Emrullah |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Anaphylactic reactions presenting with hypertension |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background Although a few case reports about hypertensive anaphylaxis (HA) are available in the present literature, there is no study about the prevalence of HA. In this study, we review our cases with anaphylaxis presenting with hypertension and ascertain its prevalence. The documents of the patients who had anaphylactic reactions after the procedures performed for the diagnosis and treatment of allergic diseases in GATA Haydarpasa Clinic of Allergy and Immunology between January 2010 and December 2014 were retrospectively reviewed. Within the study period, 324 patients had undergone 4332 procedures in which 62 of them had developed anaphylaxis. Results During the procedures, the rate of anaphylaxis was found to be 1.43 %. The rate of HA among the anaphylaxis patients was 12.9 % (8 of 62 patients). During treatments, 2 patients received adrenaline injections without any adverse reaction. Conclusions HA may be seen at a considerable rate during an anaphylactic reaction. Anaphylaxis and hypertension can be recovered by adrenaline injection when required. According to the best of our knowledge, this study is the first original study about the prevalence of HA in English-language medical literature. | ||
| 650 | 4 | |a Anaphylactic reactions |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Hypertension |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Prevalence |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Adrenaline |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Kutlu, Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Dogru, Salim |e verfasserin |4 aut | |
| 700 | 1 | |a Ozalper, Veysel |e verfasserin |4 aut | |
| 700 | 1 | |a Cetindagli, Ibrahim |e verfasserin |4 aut | |
| 700 | 1 | |a Sezer, Ogun |e verfasserin |4 aut | |
| 700 | 1 | |a Salmanoglu, Musa |e verfasserin |4 aut | |
| 700 | 1 | |a Kilic, Erol |e verfasserin |4 aut | |
| 700 | 1 | |a Karabacak, Ercan |e verfasserin |4 aut | |
| 700 | 1 | |a Ozturk, Sami |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t SpringerPlus |d London : Biomed Central, 2012 |g 5(2016), 1 vom: 02. Aug. |w (DE-627)SPR032746148 |w (DE-600)2661116-8 |x 2193-1801 |7 nnns |
| 773 | 1 | 8 | |g volume:5 |g year:2016 |g number:1 |g day:02 |g month:08 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s40064-016-2913-y |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 5 |j 2016 |e 1 |b 02 |c 08 | ||